ImmuPharma plc (AIM:IMM)
London
· Delayed Price · Currency is GBP · Price in GBX 6.38
+0.38 (6.33%)
At close: Dec 5, 2025
ImmuPharma Employees
ImmuPharma had 6 employees as of December 31, 2024. The number of employees increased by 1 or 20.00% compared to the previous year.
Employees
6
Change (1Y)
1
Growth (1Y)
20.00%
Revenue / Employee
n/a
Profits / Employee
-655.75K GBP
Market Cap
32.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,190 |
ImmuPharma News
- 11 days ago - FTSE Flat as Wall Street Gains Fail to Inspire - Investomania
- 11 days ago - AIM Market Roundup: Trellus Health, Great Western Mining, EMV Capital - The Armchair Trader
- 3 months ago - AIM Market Roundup: ImmuPharma, Rockfire Resources, Likewise - The Armchair Trader
- 3 months ago - AIM Market Roundup: Dewhurst, Metir, Tertiary Minerals - The Armchair Trader
- 3 months ago - AIM Market Roundup: ImmuPharma, N4 Pharma, Versarien - The Armchair Trader
- 4 months ago - AIM Market Roundup: Catenai, Europa Oil & Gas, Faron Pharma - The Armchair Trader
- 4 months ago - FTSE Rises as Investors Eye Tariff Deadline - Investomania
- 9 months ago - FX positioning info - Net speculative EUR longs surged in a sharp rise from previous week - Forexlive